临床医学工程
臨床醫學工程
림상의학공정
Clinical Medical & Engineering
2015年
11期
1453-1454
,共2页
重组人促红细胞生成素%慢性病性贫血%临床疗效
重組人促紅細胞生成素%慢性病性貧血%臨床療效
중조인촉홍세포생성소%만성병성빈혈%림상료효
Recombinant human erythropoietin%Anemia of chronic disease%Clinical effect
目的 探讨重组人促红细胞生成素治疗慢性病性贫血的临床疗效. 方法 选取在我院接受治疗的慢性病性贫血患者共120例, 分为观察组和对照组各60例. 所有患者原发性疾病的治疗方法不变, 给予对照组常规治疗, 给予观察组重组人促红细胞生成素治疗, 观察比较两组的治疗效果. 结果 观察组总有效率为95.0%, 明显高于对照组的70.0%, 差异具有统计学意义(P<0.05); 观察组血红蛋白、 平均血红蛋白浓度、 平均血红蛋白量、 平均红细胞体积以及红细胞分布宽度均优于对照组, 差异具有统计学意义 (P<0.05). 结论 采用重组人促红细胞生成素治疗慢性病性贫血疾病具有良好的临床效果, 值得推广.
目的 探討重組人促紅細胞生成素治療慢性病性貧血的臨床療效. 方法 選取在我院接受治療的慢性病性貧血患者共120例, 分為觀察組和對照組各60例. 所有患者原髮性疾病的治療方法不變, 給予對照組常規治療, 給予觀察組重組人促紅細胞生成素治療, 觀察比較兩組的治療效果. 結果 觀察組總有效率為95.0%, 明顯高于對照組的70.0%, 差異具有統計學意義(P<0.05); 觀察組血紅蛋白、 平均血紅蛋白濃度、 平均血紅蛋白量、 平均紅細胞體積以及紅細胞分佈寬度均優于對照組, 差異具有統計學意義 (P<0.05). 結論 採用重組人促紅細胞生成素治療慢性病性貧血疾病具有良好的臨床效果, 值得推廣.
목적 탐토중조인촉홍세포생성소치료만성병성빈혈적림상료효. 방법 선취재아원접수치료적만성병성빈혈환자공120례, 분위관찰조화대조조각60례. 소유환자원발성질병적치료방법불변, 급여대조조상규치료, 급여관찰조중조인촉홍세포생성소치료, 관찰비교량조적치료효과. 결과 관찰조총유효솔위95.0%, 명현고우대조조적70.0%, 차이구유통계학의의(P<0.05); 관찰조혈홍단백、 평균혈홍단백농도、 평균혈홍단백량、 평균홍세포체적이급홍세포분포관도균우우대조조, 차이구유통계학의의 (P<0.05). 결론 채용중조인촉홍세포생성소치료만성병성빈혈질병구유량호적림상효과, 치득추엄.
Objective To explore the clinical effect of recombinant human erythropoietin for the treatment of anemia of chronic disease. Methods 120 patients with anemia of chronic disease admitted to our hospital were selected and divided into two groups equally. On the basis of therapy for primary disease, the control group received routine treatment, while the observation group received recombinant human erythropoietin. The clinical effects of two groups were observed and compared. Results The total effective rate of observation group was 95.0%, significantly higher than 70.0% of control group (P <0.05). The observation group was superior to the control group in the hemoglobin, average corpuscular hemoglobin concentration, average corpuscular hemoglobin amount, average red blood cell volume and red blood cell distribution width (all P<0.05). Conclusions Recombinant human erythropoietin for the treatment of anemia of chronic disease has significant effect, which is worthy of promotion.
